CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma
Zhixing Xu,Haitao Xu,Xi Chen,Xiaobing Huang,Jintao Tian,Jinxi Zhao,Bohu Liu,Fengcai Shi,Jin Wu,Jun Pu
DOI: https://doi.org/10.2147/ott.s429958
IF: 4
2023-10-18
OncoTargets and Therapy
Abstract:Zhixing Xu, 1, 2, &ast Haitao Xu, 1, &ast Xi Chen, 1, &ast Xiaobing Huang, 1 Jintao Tian, 1 Jinxi Zhao, 1 Bohu Liu, 1 Fengcai Shi, 2 Jin Wu, 2 Jun Pu 1 1 Department of Neurosurgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650223, People's Republic of China; 2 Department of Neurosurgery, The Pu'er People's Hospital, Pu'er, 665000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jin Wu; Jun Pu, Email ; Background: The Coiled-coil domain-containing proteins (CCDCs) are expressed in many cancers, but the role of Coiled-coil domain-containing protein 103 (CCDC103) in cancers remains unclear. Further investigations are necessary to ascertain its diagnostic significance and understand its biological function in cancers. This study aims to elucidate the biological functionalities of CCDC103 in glioma and evaluate the correlation between CCDC103 expression with glioma progression. Methods: Clinical data on glioma patients were acquired from The Cancer Genome Atlas (TCGA), the Chinese Glioma Genome Atlas (CGGA), and the Gene Expression Omnibus (GEO). The evaluation encompassed the examination of correlations between CCDC103 expression, pathological characteristics, and clinical outcomes. Furthermore, the analysis included the assessment of the correlations between CCDC103 expression and immune cell infiltration as well as glioma progression. Results: Gliomas have higher levels of CCDC103 expression than the para-carcinoma tissues. Poorer prognosis, unfavorable histological characteristics, the absence of IDH gene mutations, and the absence of chromosome 1p and 19q deletions were all associated with higher expression of CCDC103 in gliomas. In addition to patient age, tumor grade, the absence of IDH mutations, and the absence of chromosome 1p and 19q deletions, univariate and multivariate Cox analyses showed that CCDC103 expression was independently prognostic of overall survival, disease-free survival, and progression-free survival in patients with glioma. Furthermore, tumor infiltration of B cells, neutrophils, macrophages, and dendritic cells were all linked with elevated expression of CCDC103. High CCDC103 expression was linked to immune response-related signaling pathways and cell proliferation, according to gene set enrichment analysis (GSEA). Notably, the knockdown of CCDC103 in glioma cell lines resulted in a significant reduction in cell proliferation and migration. Conclusion: The correlation between CCDC103 expression and both glioma progression and immune cell infiltration implies that CCDC103 expression holds promise as a valuable prognostic biomarker for glioma. Keywords: glioma, CCDC103, prognosis, biomarker, immune infiltration Gliomas originate from brain glial cells. It is the most common primary intracranial tumor, accounting for about 81% of malignant tumors in the central nervous system. 1 Temozolomide combined with radiotherapy and chemotherapy is the standard treatment after surgery. However, the median survival time of patients is still not more than 2 years. 2 The discovery of functional lymphatic vessels within the dural sinuses unveils fresh evidence supporting active immune surveillance in the central nervous system (CNS). Novel therapeutic avenues for glioma treatment encompass immune checkpoint inhibitors (ICIs), viral therapy, CAR-T therapy, and vaccine treatment. 3 However, the present immunotherapy options for glioma exhibit inadequate therapeutic efficacy due to the intricate immunosuppressive environment and systemic immunosuppression prevalent in gliomas. Hence, the quest for novel immune-related indicators and therapeutic targets remains pivotal in fostering advancements in glioma treatment. Recent research has demonstrated that tumor cells may adapt their actin cytoskeleton in order to respond to a wide range of complicated mechanical, biochemical, and microenvironmental cues. 4 For instance, cells can influence cell proliferation, control changes in cell shape and the structure of the actin skeleton through integrins, and attach to certain extracellular matrix (ECM) proteins. 5 Similar to this, the development of F-actin stress fibers and actin cytoskeletal polymers, which are better able to respond to changes in the extracellular matrix, are crucial for the advancement of the cell cycle. 6,7 Actin/globin and microtubules are both involved in the nuclear migration of glioma cells, according to studies. 8 The formation of dynamin-cortactin complexes and the phosphorylat -Abstract Truncated-
oncology,biotechnology & applied microbiology